DK1432443T3 - Angiotensinpeptid-bærerkonjugater og anvendelser deraf - Google Patents

Angiotensinpeptid-bærerkonjugater og anvendelser deraf

Info

Publication number: DK1432443T3
Authority: DK; Denmark
Prior art keywords: conjugates; angiotensin; peptide carrier; carrier conjugates; angiotensin peptide
Prior art date: 2001-10-05

Application number

DK02800605T

Other languages

English (en)

Inventor

Martin Bachmann

Original Assignee

Cytos Biotechnology Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-05

Filing date

2002-10-07

Publication date

2009-05-04

2002-01-18 Priority claimed from US10/050,902 external-priority patent/US7264810B2/en

2002-10-07 Application filed by Cytos Biotechnology Ag filed Critical Cytos Biotechnology Ag

2002-10-07 Priority claimed from PCT/EP2002/011219 external-priority patent/WO2003031466A2/en

2009-05-04 Application granted granted Critical

2009-05-04 Publication of DK1432443T3 publication Critical patent/DK1432443T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0013—Therapeutic immunisation against small organic molecules, e.g. cocaine, nicotine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Urology & Nephrology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Vascular Medicine (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Mycology (AREA)
Hospice & Palliative Care (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK02800605T 2001-10-05 2002-10-07 Angiotensinpeptid-bærerkonjugater og anvendelser deraf DK1432443T3 (da)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US32699801P	2001-10-05	2001-10-05
US33104501P	2001-11-07	2001-11-07
US10/050,902 US7264810B2 (en)	2001-01-19	2002-01-18	Molecular antigen array
PCT/IB2002/000166 WO2002056905A2 (en)	2001-01-19	2002-01-21	Molecular antigen array
US39663702P	2002-07-19	2002-07-19
PCT/EP2002/011219 WO2003031466A2 (en)	2001-10-05	2002-10-07	Angiotensin peptide-carrier conjugates and uses thereof

Publications (1)

Publication Number	Publication Date
DK1432443T3 true DK1432443T3 (da)	2009-05-04

Family

ID=32996249

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02800605T DK1432443T3 (da)	2001-10-05	2002-10-07	Angiotensinpeptid-bærerkonjugater og anvendelser deraf

Country Status (11)

Country	Link
EP (1)	EP2090319A3 (da)
JP (1)	JP2010189406A (da)
KR (1)	KR101015508B1 (da)
AT (1)	ATE421334T1 (da)
BR (1)	BR0213117A (da)
DE (1)	DE60230992D1 (da)
DK (1)	DK1432443T3 (da)
HK (1)	HK1067057A1 (da)
IL (1)	IL160286A0 (da)
MX (1)	MXPA04002644A (da)
PL (1)	PL369796A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN107519498A (zh) *	2011-04-15	2017-12-29	国立大学法人大阪大学	Dna疫苗
WO2016112921A1 (en)	2015-01-15	2016-07-21	University Of Copenhagen	Virus-like particle with efficient epitope display
EP3368068B1 (en)	2015-10-30	2020-11-18	University of Copenhagen	Virus like particle with efficient epitope display
WO2021205077A1 (en)	2020-04-09	2021-10-14	Finncure Oy	Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses
US12194157B2 (en)	2020-04-09	2025-01-14	Finncure Oy	Carrier for targeted delivery to a host

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4722840A (en)	1984-09-12	1988-02-02	Chiron Corporation	Hybrid particle immunogens
US4918166A (en)	1987-04-10	1990-04-17	Oxford Gene Systems Limited	Particulate hybrid HIV antigens
NZ235315A (en)	1989-09-19	1991-09-25	Wellcome Found	Chimaeric hepadnavirus core antigen proteins and their construction
EP1690935A3 (en)	1990-01-12	2008-07-30	Abgenix, Inc.	Generation of xenogeneic antibodies
US5334394A (en)	1990-06-22	1994-08-02	The Regents Of The University Of California	Human immunodeficiency virus decoy
SE9003978D0 (sv)	1990-12-13	1990-12-13	Henrik Garoff	Dna expressionssystem baserade paa ett virus replikon
GB9101550D0 (en)	1991-01-24	1991-03-06	Mastico Robert A	Antigen-presenting chimaeric protein
GB9114003D0 (en)	1991-06-28	1991-08-14	Mastico Robert A	Chimaeric protein
GB9227068D0 (en)	1992-12-29	1993-02-24	British Bio Technology	Novel proteinaceous particles
WO1994017813A1 (en)	1993-02-08	1994-08-18	Paravax, Inc.	Defective sindbis virus vectors that express toxoplasma gondii p30 antigens
US6015686A (en)	1993-09-15	2000-01-18	Chiron Viagene, Inc.	Eukaryotic layered vector initiation systems
WO1996030523A2 (en)	1995-03-31	1996-10-03	Hans Wolf	Antigen presentation system based on retrovirus-like particles
US5876727A (en)	1995-03-31	1999-03-02	Immulogic Pharmaceutical Corporation	Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
US5792462A (en)	1995-05-23	1998-08-11	University Of North Carolina At Chapel Hill	Alphavirus RNA replicon systems
ID18046A (id)	1996-08-20	1998-02-19	Takeda Chemical Industries Ltd	Senyawa siklik campuran, pembuatan dan penngunaannya.
US5770380A (en)	1996-09-13	1998-06-23	University Of Pittsburgh	Synthetic antibody mimics--multiple peptide loops attached to a molecular scaffold
EP1001978B1 (en) *	1997-06-24	2005-03-30	Proteus Molecular Design Limited	Angiotensin derivatives
US6231864B1 (en)	1998-02-12	2001-05-15	Immune Complex Corporation	Strategically modified hepatitis B core proteins and their derivatives
SE9801923D0 (sv)	1998-05-29	1998-05-29	Independent Pharmaceutical Ab	Nicotine vaccine
DE69929232T2 (de) *	1998-10-21	2006-08-31	The United States Government As Represented By The Department Of Health And Human Services	Virusähnliche partikel zur induktion von autoantikörpern
CN100534529C (zh) *	1998-11-30	2009-09-02	希托斯生物技术股份公司	抗原的有序分子呈递，制备及使用的方法
ATE336502T1 (de)	2000-04-07	2006-09-15	Univ Leeds	Hepatitis b kernprotein fusionsproteine
WO2001085208A2 (en) *	2000-05-05	2001-11-15	Cytos Biotechnology Ag	Molecular antigen arrays and vaccines
ES2260235T3 (es)	2000-06-22	2006-11-01	Ucb Pharma Limited	Modificacion del antigeno "core" de la hepatitis b.
US20030138769A1 (en)	2000-08-16	2003-07-24	Birkett Ashley J.	Immunogenic HBc chimer particles having enhanced stability
US7264810B2 (en)	2001-01-19	2007-09-04	Cytos Biotechnology Ag	Molecular antigen array

2002
- 2002-01-21 BR BR0213117-0A patent/BR0213117A/pt not_active IP Right Cessation
- 2002-01-21 MX MXPA04002644A patent/MXPA04002644A/es active IP Right Grant
- 2002-10-07 KR KR1020047002222A patent/KR101015508B1/ko not_active IP Right Cessation
- 2002-10-07 PL PL02369796A patent/PL369796A1/xx not_active Application Discontinuation
- 2002-10-07 EP EP09150826A patent/EP2090319A3/en not_active Withdrawn
- 2002-10-07 DK DK02800605T patent/DK1432443T3/da active
- 2002-10-07 DE DE60230992T patent/DE60230992D1/de not_active Expired - Lifetime
- 2002-10-07 IL IL16028602A patent/IL160286A0/xx not_active IP Right Cessation
- 2002-10-07 AT AT02800605T patent/ATE421334T1/de not_active IP Right Cessation
2004
- 2004-12-23 HK HK04110188.7A patent/HK1067057A1/xx not_active IP Right Cessation
2010
- 2010-04-01 JP JP2010085112A patent/JP2010189406A/ja active Pending

Also Published As

Publication number	Publication date
KR101015508B1 (ko)	2011-02-16
BR0213117A (pt)	2004-09-21
IL160286A0 (en)	2004-07-25
DE60230992D1 (de)	2009-03-12
EP2090319A2 (en)	2009-08-19
KR20050034573A (ko)	2005-04-14
EP2090319A3 (en)	2009-10-28
MXPA04002644A (es)	2004-07-08
HK1067057A1 (en)	2005-04-01
PL369796A1 (en)	2005-05-02
ATE421334T1 (de)	2009-02-15
JP2010189406A (ja)	2010-09-02

Publication	Publication Date	Title
WO2003031466A3 (en)	2003-10-23	Angiotensin peptide-carrier conjugates and uses thereof
EP1373301A4 (en)	2005-12-21	WEAKNESS OF IMMUNOGENICITY OF FUSION PROTEINS
MXPA03006093A (es)	2005-02-14	Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
EP1553975B8 (en)	2023-04-12	Optimized fc variants and methods for their generation
MY162525A (en)	2017-06-15	Process for concentration of antibodies and therapeutic products thereof
ATE542829T1 (de)	2012-02-15	Impfstoff
DK0918848T3 (da)	2007-04-10	Fremgangsmåder til at behandle kræftsygdomme og patogene infektioner ved anvendelse af antigenpræsenterende celler påfyldt med RNA
ES2291311T3 (es)	2008-03-01	3-cianoquinolinas, 3-ciano-1,6-naftiridinas y 3-ciano-1,7-naftiridinas como inhibidores de proteina quinasas.
HK1046016B (zh)	2009-02-27	疫苗中的重組脫氧核糖核酸膠原
DK1259547T3 (da)	2012-10-15	Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf
MXPA04006059A (es)	2004-09-27	Preparacion liofilizada que contiene anticuerpos contra el receptor del factor de crecimiento epidermico.
MXPA04004814A (es)	2004-08-11	Metodos para descubrir ligandos.
ATE551069T1 (de)	2012-04-15	Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
HK1068112A1 (en)	2005-04-22	Method of forming an optical tools
AU2002323221A1 (en)	2003-06-17	Process for manufacture of molecular sieves
DK1432443T3 (da)	2009-05-04	Angiotensinpeptid-bærerkonjugater og anvendelser deraf
EE200500012A (et)	2005-08-15	Peptiid-pähine passiivne immunoteraapia ateroskleroosi raviks
ATE262600T1 (de)	2004-04-15	Herstellung von aluminium-silizium-legierungen
MY138698A (en)	2009-07-31	Method for synthesis of (2s)-indoline-2-carboxylic acid, and use in the synthesis of perindopril
ATE471990T1 (de)	2010-07-15	Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln
DE59610629D1 (de)	2003-09-04	Immunogenes konstrukt, verfahren zu dessen herstellung und verwendung als vakzine
WO2003011903A3 (en)	2004-05-06	Identification of specific tumor antigens by means of the selection of cdna libraries with sera
DK1209159T3 (da)	2005-01-24	Fremgangsmåde til fremstilling af vandfrie mirtazapinkrystaller
ATE413887T1 (de)	2008-11-15	Stress-protein-peptidkomplexe als impfstoffe gegen intrazelluläre pathogene
TW200503750A (en)	2005-02-01	FSH and LH pharmaceutical formulations